| Medical Devices / Diagnostics News From Medical News Today Latest Health News and Medical News posted throughout the day, every day. |
| Thu, 02 Sep 2010 04:00:00 PDT Bausch + Lomb Releases Single-Use Vitreoretinal Asymmetric Peeling Forceps Bausch + Lomb Storz® Ophthalmic Instruments announces the U.S. release of a new, single-use, asymmetric peeling forceps for vitreoretinal surgery. The forceps are available in 23- and 25-gauge options for facilities seeking the safety, consistency and convenience a single-use instrument offers... Click here to read this news article. |
| Thu, 02 Sep 2010 03:00:00 PDT Cancer Center To Be The First In Europe To Install A CyberKnife VSI System, The Latest Generation Of The CyberKnife System Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family... Click here to read this news article. |
| Thu, 02 Sep 2010 03:00:00 PDT Two-Hour Test For TB Reported To Be Clinically Effective Research assessing the effectiveness of a new diagnostic test for the detection of tuberculosis (TB) is featured in the Sept. 1 edition of the New England Journal of Medicine... Click here to read this news article. |
| Thu, 02 Sep 2010 02:00:00 PDT Abbott Receives FDA Approval For First Automated Molecular Test For Assessing Hepatitis B Treatment Abbott (NYSE: ABT) announced it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results... Click here to read this news article. |
| Thu, 02 Sep 2010 02:00:00 PDT Unilife Corporation Secures FDA 510k Clearance For The Unitract? 1mL Tuberculin Syringe Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS, ASX: UNS), announced that its Unitract? Tuberculin (TB) Syringe has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA). The Unitract? TB syringe is a variant of the Unitract? 1mL Insulin Syringe for which Unilife secured FDA clearance earlier this year... Click here to read this news article. |
| Thu, 02 Sep 2010 02:00:00 PDT New England Journal Of Medicine Study Shows New Molecular TB Test Could Offer Rapid And Effective Diagnosis In Developing Countries A study(1) published in The New England Journal of Medicine reports that a new molecular tuberculosis (TB) test, Xpert® MTB/RIF, provides highly sensitive detection of tuberculosis and drug resistance in low resource settings more easily and in significantly less time than any current, widely used diagnostic... Click here to read this news article. |
| Thu, 02 Sep 2010 02:00:00 PDT Open House At Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® To Community Gulf Coast Cancer Treatment Center, the area's only American College of Radiology-accredited radiation oncology center, introduces the Elekta Synergy system. The new technology will be showcased at the center's Open House on Thursday, September 16, 2010 from 1 p.m. to 7 p.m. Gulf Coast Cancer Treatment Center (GCCTC) is located at 2100 State Avenue in Panama City. Radiation oncologists Dr. D.B... Click here to read this news article. |
| Thu, 02 Sep 2010 02:00:00 PDT Varian Medical Systems Establishes Radiotherapy Training Center In Mumbai, India Varian Medical Systems (NYSE: VAR), a world leader in radiotherapy equipment and software, has established its first education center in India to train medical physicists and technologists working on the company's advanced cancer treatment systems... Click here to read this news article. |
| Thu, 02 Sep 2010 01:00:00 PDT European Collaborative Research To Develop Lab-on-chip System For Cheap And Fast Cancer Diagnosis Detection of circulating and disseminated tumor cells in blood is a promising methodology to diagnose cancer dissemination or to follow up cancer patients during therapy. Today, the detection analyses of these cells are performed in medical laboratories requiring labor intensive, expensive and time-consuming sample processing and cell isolation steps... Click here to read this news article. |
| Thu, 02 Sep 2010 00:00:00 PDT Battling Cancer: New Infrared Light May Open New Frontier In The Fight A "game-changing" technique using near infrared light enables scientists to look deeper into the guts of cells, potentially opening up a new frontier in the fights against cancer and many other diseases. University of Central Florida chemists, led by Professor Kevin Belfield, used near infrared light and fluorescent dye to take pictures of cells and tumors deep within tissue... Click here to read this news article. |
| Wed, 01 Sep 2010 04:00:00 PDT Improving Ocular Disease Screening By LED Illumination Of The Eye A new imaging system using six different wavelengths to illuminate the interior of the eyeball (ocular fundus) may pave the way for doctors to easily screen patients for common diseases of the eye, such as age-related macular degeneration and diabetic retinopathy. The system is described in the journal Review of Scientific Instruments, which is published by the American Institute of Physics... Click here to read this news article. |
| Wed, 01 Sep 2010 03:00:00 PDT Prometheus Launches The First Serogenetic Test To Predict Risk Of Complications From Crohn's Disease Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test... Click here to read this news article. |
| Wed, 01 Sep 2010 03:00:00 PDT Swiss Breast Cancer Patient Becomes First In World To Receive Treatment Using Gated RapidArc From Varian Medical Systems A 51-year-old breast cancer patient from Switzerland has become the first person in the world to be treated using Gated RapidArc®, which makes it possible to monitor patient breathing and compensate for tumor motion while quickly delivering radiotherapy during a continuous rotation around the patient... Click here to read this news article. |
| Wed, 01 Sep 2010 03:00:00 PDT OrthoAccel Technologies Announces Full-Market Release Of AcceleDent, A New Technology To Shorten Treatment Time In Braces OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September... Click here to read this news article. |
| Wed, 01 Sep 2010 02:00:00 PDT Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery Masimo (Nasdaq: MASI) announced that a new randomized controlled trial published in Anesthesia & Analgesia shows that clinicians using Masimo Pleth Variability Index (PVI®) significantly improved fluid management and reduced lactate levels in patients during and after surgery, compared to patients managed by standard care without PVI(1)... Click here to read this news article. |
| Wed, 01 Sep 2010 02:00:00 PDT Eyegenix? Artificial Cornea Achieves Major Advancement Towards Curing Corneal Blindness Eyegenix?, the ophthalmic division of Cellular Bioengineering, Inc. (CBI), announced that the results of a pilot clinical trial using a synthetic cornea for which Eyegenix? holds the exclusive global license for transplantation were published in the peer-reviewed journal, Science Translational Medicine (Volume 2, Issue 46, August, 25, 2010)... Click here to read this news article. |
| Wed, 01 Sep 2010 02:00:00 PDT CORDIS Announces Results Of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety and were publ... Click here to read this news article. |
| Wed, 01 Sep 2010 02:00:00 PDT InSightec Treats First Prostate Cancer Patients In Clinical Trials nSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients. Seven patients with localized low-risk prostate cancer were treated worldwide so far... Click here to read this news article. |
| Wed, 01 Sep 2010 02:00:00 PDT Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients In Clinical Trials Elbit Imaging Ltd. (NASDAQ: EMITF) ("Elbit" "Company") that it's subsidiary, InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients... Click here to read this news article. |
| Wed, 01 Sep 2010 02:00:00 PDT MonoSol Rx Announces Reckitt Benckiser FDA Approval Of Suboxone® Sublingual Film For Treatment Of Opioid Dependence MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, Reckitt Benckiser Pharmaceuticals Inc., a wholly-owned subsidiary of Reckitt Benckiser Group plc (LSE: RB), has received approval from the U.S... Click here to read this news article. |
| Tue, 31 Aug 2010 11:00:00 PDT Hip Replacement Recall By Depuy Orthopaedics Is Big News Due to a fairly high percentage (12-13%) of five year revision or secondary hip surgeries DePuy Orthopaedics, Inc. reported based on this year's data from the National Joint Registry (NJR) of England and Wales, the manufacturer announced this week it is voluntarily pulling the ASR? XL Acetabular System and DePuy ASR? Hip Resurfacing System from the marketplace... Click here to read this news article. |
| Tue, 31 Aug 2010 08:00:00 PDT Blood Clot Risk More Than Double In Black Americans Implanted With Drug-Coated Stents A new study found that black Americans implanted with drug-coated stents have more than double the risk of developing life-threatening blood clots than Americans from other races who have also had drug-coated stents implanted to prop open narrowing arteries. You can read about the study behind these findings in Circulation: Journal of the American Heart Association... Click here to read this news article. |
| Tue, 31 Aug 2010 04:00:00 PDT 'Toolbox Of MiniPromoters' For Gene Research And Therapy Unvelied By UBC Researchers University of British Columbia researchers have led the development of a new "toolbox of MiniPromoters" for research and future therapies on brain, spinal cord and eye function. MiniPromoters are small segments of human DNA with the ability to turn genes on and off at specific times and locations... Click here to read this news article. |
| Tue, 31 Aug 2010 04:00:00 PDT Improved Tool For Cycling Fitness Developed By UNH Researchers For competitive bicyclists with goals - whether competing in the Tour de France or aiming for the podium at a local race - faster cycling comes from training regimens based on various zones of exercise intensity... Click here to read this news article. |
| Tue, 31 Aug 2010 04:00:00 PDT Collection, Analysis Of Hard-To-Handle Immune Cells Enabled By Microfluidic Device A team led by Massachusetts General Hospital (MGH) scientists has developed a new microfluidic tool for quickly and accurately isolating neutrophils - the most abundant type of white blood cell - from small blood samples, an accomplishment that could provide information essential to better understanding the immune system's response to traumatic injury... Click here to read this news article. |
 Personal Injury Law Motor Vehicle Accidents Car Accidents Tractor Trailer / Big Truck Accidents Motorcycle Accidents Dram Shop LiabilityInjuries Caused By Intoxicated PersonsAirplane Accidents Railroad Accidents Boat Accidents Cruise Ship Accidents Bicycle Accidents Pedestrian Accidents Premises Liability Dog Bites / Animal Attacks Slip and Fall Accidents Negligent Security Construction Accidents Workers' Compensation Social Security Disability Other Disability Claims Medical Malpractice Nursing Home Negligence Dangerous Drugs Hazardous Products Environmental Pollutants Consumer Fraud Job Discrimination Wage And Hour Claims Police Brutality Traffic Violations DUI / Drunk Driving Charges Criminal Defense Real Estate Law Family Law Divorce Law Bankruptcy Business Law Wills and Trusts Estate Planning  Anatomy Wrongful Death Spinal Cord Injury Paralysis Head and Brain Injuries Birth Injuries Cerebal Palsy Mesothelioma Amputation Disc Herniation Fractures Soft Tissue Injuries Burn Injuries Reflex Sympathetic Dystrophy Stevens-Johnson Syndrome Bed Sores  Amount of Damages Factors Affecting Damage Awards Types of Damages     The Civil Justice System Know Your Rights  Attorneys Help UnSung Heroes Consumer Attorneys Care  
|
|
 
  
  
|
| © 2010 VanDerGinst Law, PC & MegaHunter, Inc., Website Design & Development. All Rights Reserved. |